title: The Values of Coronary Circulating miRNAs in Patients with Atrial Fibrillation.
abstract: The mechanism of miRNA regulation in atrial fibrillation (AF) occurrence and development is still unclear, especially, the regulating values of coronary circulating miRNAs has not been reported. Based on our AF radiofrequency ablation clinical practice and previous miRNA study, we proposed a hypothesis that the coronary circulating miRNA might much better reflect the regulating state and metabolic level of myocardial miRNA in AF patient. To investigate the regulating values of coronary circulation miRNA, 90 AF patients were selected and compared with 90 healthy subjects, the changes of coronary circulating miRNA differential expression profile in the whole genome were observed in this study. We found out that compared with autologous peripheral blood (PB), 6 miRNAs were upregulated and 8 miRNA downregulated in AF patients' coronary sinus blood (CSB) significantly, especially, the expression of miR-1266, miR-4279 and miR-4666a-3p were obviously increased. Compared with normal donors' peripheral blood, 16 miRNAs were upregulated and 24 miRNAs downregulated dramatically in patients' peripheral blood, among them, the miR-3171 decreased, but miR-892a and miR-3149 increased significantly from the early to end stages of AF. Our results indicated that the coronary circulating miRNA can really reflect the regulating values of miRNA in AF patient; the level of miRNA change in 3 types of AF may reflect the severity of AF clinical and pathophysiological advance; The miR-892a, miR-3171 and miR-3149 may be used as biomarkers for earlier diagnosis, while miR-1266, miR-4279 and miR-4666a-3p may serve as potential intervening targets for AF patient in future.
authors.affiliation: The Department of Cardiology, Capital Medical University Affiliated Beijing Shijitan Hospital, Beijing, China.
authors.forename: Guiyu
authors.initials: G
authors.lastname: Xu
authors.affiliation: The Department of Cardiology, Capital Medical University Affiliated Beijing Shijitan Hospital, Beijing, China.
authors.forename: Yuxia
authors.initials: Y
authors.lastname: Cui
authors.affiliation: The Dept. of Cardiology, Hebei Medical University Affiliated Yiling Hospital, Hebei, China.
authors.forename: Zhenghua
authors.initials: Z
authors.lastname: Jia
authors.affiliation: The Department of Cardiology, Capital Medical University Affiliated Beijing Shijitan Hospital, Beijing, China.
authors.forename: Yunan
authors.initials: Y
authors.lastname: Yue
authors.affiliation: The Department of Cardiology, Capital Medical University Affiliated Beijing Shijitan Hospital, Beijing, China.|The Dept. of Cardiology, Hebei Medical University Affiliated Yiling Hospital, Hebei, China.
authors.forename: Shuixiang
authors.initials: S
authors.lastname: Yang
mesh_terms: D000368:Aged; D001281:Atrial Fibrillation / Q000097:blood* / Q000235:genetics*; D016022:Case-Control Studies; D016000:Cluster Analysis; D003326:Coronary Circulation / Q000235:genetics; D054326:Coronary Sinus / Q000378:metabolism; D005260:Female; D020869:Gene Expression Profiling; D006801:Humans; D008297:Male; D035683:MicroRNAs / Q000097:blood* / Q000235:genetics / Q000378:metabolism; D060888:Real-Time Polymerase Chain Reaction; D015203:Reproducibility of Results
chemical_list: D035683:MicroRNAs